Skip to main content

Table 3 Factors associated with time to mortality for patients on ART in central Kenya between 2004 and 2012 after 36 months of follow up

From: Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya

  Univariable Multivariable
SHR (95% CI) p value SHR (95% CI) p value
Age groups
 0–4 Ref   Ref  
 5–9 1.17 (0.72–1.91) 0.529 0.84 (0.41–1.72) 0.633
 10–14 1.72 (1.03–2.86) 0.037 1.01 (0.46–2.20) 0.979
 15–19 0.80 (0.37–1.75) 0.575 0.54 (0.19–1.52) 0.239
 20–35 1.36 (0.94–1.98) 0.108 1.42 (0.81–2.50) 0.224
 36–50 1.65 (1.14–2.39) 0.008 1.59 (0.90–2.80) 0.107
 51 and above 2.36 (1.59–3.51)  < 0.001 2.40 (1.32–4.34) 0.004
Sex
 Female Ref   Ref  
 Male 1.63 (1.44–1.86)  < 0.001 1.63 (1.38–1.91)  < 0.001
Marital status
 Single 1.47 (1.25–1.74)  < 0.001 1.75 (1.42–2.15)  < 0.001
 Married Ref   Ref  
 Divorced 1.37 (1.13–1.67) 0.001 1.33 (1.07–1.65) 0.010
 Widowed 1.31 (1.05–1.63) 0.016 1.29 (1.01–1.66) 0.044
Regimen started
 TDF based Ref   Ref  
 D4T based 1.82 (1.51–2.20)  < 0.001 1.31 (1.00–1.72) 0.050
 AZT based 1.30 (1.04–1.63) 0.021 1.15 (0.87–1.51) 0.339
 ABC based 0.81 (0.52–1.25) 0.335 1.21 (0.72–2.05) 0.480
Baseline WHO stage
 Stage 1 Ref   Ref  
 Stage 2 1.82 (1.40–2.37)  < 0.001 1.42 (1.06–1.91) 0.020
 Stage 3 3.14 (2.45–4.03)  < 0.001 2.01 (1.50–2.68)  < 0.001
 Stage 4 5.42 (4.05–7.24)  < 0.001 4.21 (2.98–5.96)  < 0.001
TB status
 ON TB TX Ref   Ref  
 No signs 10.50 (7.87–14.02)  < 0.001 8.67 (6.22–12.10)  < 0.001
 Presumptive TB 8.10 (6.80–9.65)  < 0.001 6.05 (4.91–7.45)  < 0.001
ART cohort
 2004 Ref    
 2005 0.79 (0.34–1.79) 0.567 0.86 (0.26–2.77) 0.795
 2006 1.31 (0.63–2.73) 0.464 2.29 (0.83–6.34) 0.112
 2007 1.94 (0.95–3.94) 0.068 3.20 (1.18–8.68) 0.023
 2008 2.13 (1.05–4.32) 0.036 3.97 (1.46–10.77) 0.007
 2009 1.90 (0.93–3.85) 0.077 4.07 (1.50–11.07) 0.006
 2010 1.78 (0.88–3.61) 0.112 4.13 (1.50–11.33) 0.006
 2011 1.09 (0.53–2.24) 0.812 3.00 (1.07–8.46) 0.037
 2012 0.89 (0.43–1.85) 0.748 2.57 (0.90–7.32) 0.078